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Mitochondrial ATP productionGlucocorticoids are major regulators of a plethora of cellular functions, acting on target cells through
glucocorticoid receptors (GR) and modulation of gene transcription, among other mechanisms. One main site
of action of glucocorticoids is the hepatocyte, which responds to the hormonal stimulus with induction of
several proteins among them enzymes of oxidative phosphorylation (OXPHOS), both nuclearly and
mitochondrially encoded. The induction of OXPHOS is regarded as a result of a nuclear action of the receptor
on the respective nuclear genes and on genes encoding mitochondrial transcription factors. The presence of
GR in mitochondria and of sequences in the mitochondrial genome similar to glucocorticoid responsive
elements, suggested a direct action of GR on mitochondrial transcription. We demonstrate in HepG2
hepatocarcinoma cells speciﬁc binding of GR to the regulatory D-loop region of themitochondrial genome and
show that dexamethasone induces the mitochondrial transcription factors A, B1, and B2, the mitochondrial
ribosomal RNA, and several mitochondrially encoded OXPHOS genes. Applying α-amanitin, the speciﬁc
inhibitor of DNA-dependent RNA polymerase II, the dexamethasone-induced transcription of the
mitochondrial genes can still proceeds, whereas the DEX effect on transcription of the mitochondrial
transcription factors is suppressed. Moreover, HepG2 cells overexpressing mitochondrial targeted GR showed
increased RNA synthesis, cytrochrome oxidase subunit I protein expression, and mitochondrial ATP
production. We conclude that glucocorticoids can stimulate directly mitochondrial transcription by the
mitochondrially localized GR, affecting OXPHOS enzyme biosynthesis. This takes place in addition to their
action on mitochondrial genes by way of induction of the nuclearly encoded mitochondrial transcription
factors.emistry and Biotechnology,
21, Larissa, Greece. Tel: +30
).
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Glucocorticoids are important regulators of basic cellular processes,
such asmetabolism, growth, differentiation, and survival [1]. Theirmode
of action in target cells has received considerable interest and it is now
clear that they can act in various ways, e.g., on the gene level by way of
cognate receptors and on cytoplasmic processes by way of membrane
receptors.Oneof theﬁrstmodel systemswhich led to thedemonstration
that glucocorticoids act through cognate cytoplasmic receptors to
stimulate transcription of genes and induce the respective proteins
was that of cortisol inducing in the rodent liver enzymes involved in
gluconeogenesis [2–6].
In these and later studies, a bulk increase of HnRNA containing the
pre-mRNAs of the induced genes, ribosomal RNA and t-RNA wasobserved [3–5], which could not account for the increased mRNA
synthesis corresponding to the transcription of the few genes,
identiﬁed as glucocorticoids-induced genes. Recent results from
studies involving bio-array analyses [7–9] have shown that the
glucocorticoid effect on the hepatocyte and on other target cells
encompasses several genes, and, in part, justiﬁes the observed
overwhelming increase in nuclear RNA synthesis. Mitochondrial
RNA synthesis is also stimulated by glucocorticoids [3,6]. The
hormonal induction process is highly energy consuming, and the
cell makes efforts to guarantee the replenishment of its energy
reserves. Therefore, it is understandable that the glucocorticoid
induced mitochondrial RNA synthesis can be correlated to this energy
regeneration process, as the mitochondrial genome encodes subunits
of OXPHOS enzymes and RNAs participating in the protein synthesis
inmitochondria. Due to the fact that some OXPHOS are encoded in the
nuclear genome and others in the mitochondrial genome it is
assumed, in analogy to the action of thyroid hormones on liver
OXPHOS [reviewed in 10] that the hormonal stimulus affects the
transcription of the mitochondrial encoded OXPHOS indirectly, by
inducing nuclear signals, such as mitochondrial transcription factors,
Table 1
Primers for human mitochondrial OXPHOS enzymes, COX IV, 12 S, and 16 S
mitochondrial RNA.
Forward Reverse
ND I atggccaacctcctactcctcatt ttatggcgtcagcgaagggttgta
ND II ccatctttgcaggcacactcatca attatggatgcggttgcttgcgtg
ND III gccctacaaacaactaacctgcca ataggccagacttagggctaggat
ND IV agctccatctgcctacgacaaaca taagcccgtgggcgattatgagaa
ND V cacagcagccattcaagcaatcct acctaattgggctgatttgcctgc
ND VI ataggatcctcccgaatcaaccct aggattggtgctgtgggtgaaaga
COX I accctagaccaaacctacgccaaa taggccgagaaagtgttgtgggaa
COX II acagatgcaattcccggacgtcta ggcatgaaactgtggtttgctcca
COX III tcacttccactccataacgctcct gtgttacatcgcgccatcattggt
ATP6 acattactgcaggccacctactca acgtaggcttggattaaggcgaca
ATP8 accgtatggcccaccataattacc tttatgggctttggtgagggaggt
Cyt b agtcccaccctcacacgattcttt agtaagccgagggcgtctttgatt
12 S aaactgctcgccagaacactacga tgagcaagaggtggtgaggttgat
16 S taccctcactgtcaacccaacaca ttaaacatgtgtcactgggcaggc
COX IV agaaagtcgagttgtatcgcatt gataacgagcgcggtgaaac
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mitochondrial genome. However, the demonstration of the mito-
chondrially localized glucocorticoid receptor and the presence of
sequences with strong homology and characteristics of glucocorticoid
response elements (GRE) in the mitochondrial genome [11], raised
the possibility of a direct effect of the mitochondrial GR on
mitochondrial transcription, in addition to the indirect nuclear
pathway [12,13].
We now present data demonstrating that dexamethasone (DEX), a
synthetic glucocorticoid, induces in HepG2 cells the mitochondrial
transcription factors A, B1, and B2 (TFAM, TFB1M, TFB2M), the 12 S and
16 S mitochondrial ribosomal RNA and several mitochondrial DNA
(mtDNA) encoded genes. Applyingα-amanitin, the inhibitor of the DNA-
dependent RNA polymerase II, we show that the inducing effect of
dexamethasone on the mitochondrial ribosomal RNA and the mtDNA
encoded genes can still take place in the presence of the inhibitor,
although transcription of the nuclearly encoded mitochondrial transcrip-
tion factor genes is reduced. Furthermore, we demonstrate by chromatin
immunoprecipitation (ChIP) analysis, binding of GR to sequences with
strong homology to GREs in the D-loop regulatory region of the
mitochondrial genome and provide evidence for an involvement of the
increased mitochondrial GR expression in promoting mitochondrial RNA
synthesis and mitochondrial ATP production.
2. Materials and methods
2.1. Chemicals
Dulbecco'smodiﬁed Eaglemedium (DMEM) and fetal bovine serum
(FBS)were obtained fromGibco-BRL.Molecularweight proteinmarkers
and complete protease inhibitors cocktail were purchased from
Fermentas and Roche, respectively. Lipofectamin 2000 andMitoTracker
Red CMXRos (CMX) were from Invitrogen. Geneticin (G418) was from
Calbiochem. All other chemicals including α-amanitin were purchased
from Sigma-Aldrich.
2.2. Cells culture — HepG2 cells stably expressing a mitochondrial
targeted GFP-GR fused protein (HepG2-mtGFPGR cells)
Human HepG2 cells were maintained in DMEM, supplemented
with 10% FBS, 2 mM glutamine, and penicillin/streptomycin. Cells
were grown at 37 °C in a humidiﬁed atmosphere with 5% CO2.
For stable cell lines generation, at day 1 before transfection, HepG2
cells were plated in 60-mm culture dishes so that they reached
50–70% conﬂuency at the time of transfection. To obtain stable




a mitochondrial targeting peptide was inserted in frame with the
enhanced green ﬂuorescence protein (EGFP) gene between NheI and
AgeI sites of the pEGFPC2 vector (Clontech) to produce the pmtEGFPC2
construct. Subsequently, the human glucocorticoid receptor gene
(X03225 accession no.)was inserted into the pmtEGFPC2 construct at the
BamHI site (pmtEGFPC2-GR). The produced construct was transfected
into the HepG2 cells using Lipofectamine 2000, according to the
manufacturer's instructions. Control cells (HepG2-mtGFP cells) were
prepared by transfection of the pmtEGFPC2 construct. After 24 h
incubation at 37 °C, cellswere thrypsinized and passaged at a 1:5 dilution
in selective growth medium [DMEM supplemented with 10% (v/v) FBS,
containing 1.5 mg/ml Geneticin (G418)]. On the next day, themedium in
all plateswas replacedwith freshselectivegrowthmediumandcellswere
cultured for 2 weeks. G418 resistant colonies were expanded and cloned
independently and analyzed by immunoﬂuoresence, Western blot
analysis, and immunoprecipitation to conﬁrm the expression of the
mitochondrial GFP (mtGFP) and GFP-GR (mtGFPGR) proteins.2.3. Inhibition of nuclear RNA synthesis — α-amanitin treatment
HepG2 cells grown on 6 well plates were treated with 10 μg/ml
α-amanitin, for 5 h, at 37 °C. Control as well as α-amanitin treated
cells were stimulated either with 10−6 M DEX (diluted in Ethanol), or
equal volume of ethanol for 1 h at 37 °C. Subsequently, cells were
washed with phosphate buffer saline and total RNA was extracted
using Trizol followed by DNase treatment (Promega) and reverse
transcription into cDNA, using random primers and superscript II
reverse transcriptase (Invitrogen). Expressed levels of mRNA were
quantitated using real-time RCR which was performed after mixing
the cDNA with SYBR GreenER qPCR super mix Universal (Invitrogen)
and appropriate primers. Products were quantitated with a Chromo4
Real-Time System (Bio-Rad). Conditions for PCRwere: 52 °C for 2 min,
95 °C for 2 min, 35 cycles of 95 °C for 15 s and 60 °C for 40 s, followed
by 60 °C for 10 min. Primers for mitochondrial encoded OXPHOS
genes, cytochrome oxidase subunit IV (COX IV), and 12 S and 16 S RNA
are shown in Table 1. Primers for glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) as a nuclear reference gene are: GAPDH
forward: catgagaagtatgacaacagcct; GAPDH reverse: agtcctttccacga-
taccaaagt [13].2.4. ChIP assay
HepG2 cells, grown in 15 cm Petri dishes were ﬁrst cross-linked
with formaldehyde (ﬁnal concentration, 1%) for 10 min at room
temperature, and then the reaction was stopped with glycine
(0.125 M) for 5 min at room temperature. Cells were then rinsed
twicewith ice-cold PBS, collected into ice cold PBS supplementedwith
a protease inhibitor cocktail (Roche). After centrifugation the cell
pellets were resuspended in lysis buffer (1% SDS, 10 mM EDTA 50 mM
Tris–HCl pH 8.1 and protease inhibitors). The lysates were sonicated
on ice at 30% of maximum of power (Sonics' Vibra-cell), to yield DNA
fragments of 500 to 200 bp in length. After preclearance of the resul-
ting chromatin with salmon sperm DNA-protein A/G agarose 50%
slurry (Upstate Biotechnology) for 1 h at 4 °C with agitation,
immunoprecipitation was performed overnight at 4 °C either with a
GR speciﬁc monoclonal antibody (2F8) produced and kindly provided
by Dr. M. Alexis (Hellenic Research Foundation) or normal mouse IgG
as control. Agarose beads were pelleted by centrifugation and washed
extensively according to Upstate Biotechnology instructions. Finally
the bound DNA fragments were eluted in freshly prepared elution
buffer (1% SDS, 0.1 M NaHCO3), puriﬁed, concentrated, ampliﬁed and
quantiﬁed either by semiquantative PCR or by real-time PCR. Binding
to the putative mitochondrial hormone response elements in the D-
loop, 12 S, NADH-CoQ-reductase subunit I (ND I) region was checked
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sites are as follows: D-Loop Forward (−16,549 bp): TCGCTCCGGGCCC
ATAACACTT; D-Loop Reverse (−16,449 bp): GGAACGTGTGGGCTATT
TAGGCTT; 12 S Forward (−1253 bp):AAAGGACCTGGCGGTGCTTCA
TA; 12 S Reverse (−1166 bp):GAGCAAGAGGTGGTGAGGTTGAT; ND I
Forward (−4168 bp):AGGAACAACATATGACGCACTCTCCC; ND I Re-
verse (−4036 bp):GTGTATGAGTTGGTCGTAGCGGAA. Recovery of DNA
was calculated as percentage of input material of the immunoprecipi-
tation. Myoglobin gene was used as a negative control for GR chromatin
binding. The primers sequences for myoglobin are; Forward:TGGCAC
CATGCTTCTTTAAGTC; Reverse:AAGTTTGACAAGTTCAAGCACCTG).
2.5. In organello RNA synthesis
Mitochondrial RNA synthesis was measured in faithfully transcrib-
ing isolated mitochondria from HepG2 cells as previously described
[14–16]. Brieﬂy, freshly isolated crude mitochondria (10,000×g pellet)
(produced as previously described [17]) were incubated at a ﬁnal
mitochondrial protein concentration of 2 mg/ml in 0.5 ml of incubation
buffer containing 25 mM sucrose, 75 mM sorbitol, 100 mMKCl, 10 mM
K2HPO4, 0.05 mM EDTA, 5 mM MgCl2, 1 mM ADP, 10 mM glutamate,
2.5 mM malate, 10 mM Tris–HCl (pH 7.4) and 1 mg of bovine serum
albumin. 20 μCi of [α-32P]UTP was added to the medium, and
incubation was maintained at 37 °C for 60–90min. For various time
intervals mitochondrial samples were pelleted at 13,000×g for 2 min
and the supernatant with the non incorporated [α-32P]UTP was
removed. Mitochondria were washed once and then lysed in 20 mM
Tris pH: 7.5 supplementedwith 2% SDS. The acid-insolublematerialwas
precipitated on a glass ﬁber ﬁlter with 5% trichloroacetic acid. Filter
were washed ﬁve times with 5% TCA, twice with ether, and dried.
Radioactivitywasmeasured by liquid scintillation counting. The [α-32P]
UTP was linear up to 60–90 min.
2.6. Mitochondrial ATP content measurements
Mitochondria fromHepG2-mtGFP and HepG2-mtGFPGR cells were
freshly isolated as previously described [17]. ATP from isolated
mitochondria was extracted with 1% TCA and ATP content was
measured in a luminometer (Berhold) by bioluminescence using the
luciferin-luciferase reaction-Kit (Enliten, Promega) following the
manufacturer's instructions.
2.7. Immunoprecipitation-Western blot analysis
Mitochondria from HepG2-mtGFPGR cells were lysed in RIPA
buffer (10 mM Tris/HCl, pH 8.0, 150 mM NaCl, 1 mM EDTA, 0.1%
NP-40) supplemented with protease inhibitors and sonicated for
3×20 s. Insoluble material was removed by centrifugation at
13,000×g for 15 min and the supernatants were preincubated for
1 h, with 20 μl protein A sepharose, at 4 °C. Samples were centrifuged
for 2 min at 1500×g, and the supernatants were further incubated
with the primary antibodies mouse anti-GR (2F8) or mouse anti-GFP
(Roche). Samples incubated with normal mouse IgG were used as
control. 20 μl of protein A sepharose was added to each sample and
incubated for 3 h, at 4 °C. Protein A sepharose was pelleted by
centrifugation at 1500×g for 2 min and washed three times in PBS.
The samples were boiled in SDS-PAGE loading buffer, in the presence
of 5% β-mercaptoethanol, for 4 min and centrifuged at 1500×g. The
resulting supernatants were loaded on a 10% SDS-PAGE gel, electro-
phoresed and Western blotted with speciﬁc rabbit polyclonal
antibodies against GR (GR-H300) commercially provided by Santa
Cruz Biotechnology. Cytochrome oxidase subunit I (COX I) protein
synthesis was evaluated byWestern blot analysis. Equal amount of total
protein extracts from HepG2-mtGFP and HepG2-mtGFPGR cells were
electrophoresed on a 10% SDS-PAGE gel and Western blotted with
speciﬁc mouse monoclonal antibodies against COX I (Invitrogen).Protein expression levels were normalized to β-actin protein expres-
sion using speciﬁc monoclonal antibodies commercially provided by
Sigma.2.8. Immunoﬂuorescence-confocal microscopy
Cells grown on coverslips were incubated for 30 min at 37 °C with
200 nM CMX in the presence or absence of 10−6 M DEX; washed
3×5 min with PBS, ﬁxed for 10 min in ice-cold methanol and
transferred to ice-cold acetone for 2 min. For nuclear staining
specimens were incubated with 10 ng/ml Hoechst 33342 in PBS, for
30 min at room temperature. Antibodies against GR (GR-300) were
used for GR detection. Secondary Alexa 488-conjugated antibodies
were also used and purchased from Invitrogen. The specimens were
washed in PBS andmounted in anti-fading medium [18]. Images were
taken at 23–24 °C using an inverted laser-scanning confocal micro-
scope (TCS SP5; Leica) equipped with a 63× NA 1.3 oil immersion
objective lens (Leica) and LAS-AF acquisition software (Leica).2.9. Statistical analysis
All results are expressed as mean±SD (n=3–5). Data were
analyzed both by independent t-test and Mann–Whitney test.
Differences were considered signiﬁcant at a two tailed P value b0.05.3. Results
3.1. Production of HepG2 cells stably overexpressing mitochondrial
targeted GFP-GR
In order to elucidate the role of the mitochondrial GR in
mitochondrial functions and particularly in the mitochondrial
transcription, HepG2 cells stably expressing the human GR fused
with a mitochondrial targeted green ﬂuorescence protein at its N
terminus were generated as described in material and methods. Cells
stably expressing mitochondrial GFP were also produced and used as
control.
The presence of endogenousmitochondrial GR in HepG2 cells, in the
presence or absence of DEX, is demonstrated in Fig. 1A and B
corroborating previous ﬁndings [17,19]. Cells stably overexpressing
GR fused with the mitochondrial targeted GFP protein (HepG2-
mtGFPGR) are shown in Fig. 1C, D, and E. Mitochondrial targeted
GFPGR (Fig. 1 C1, D1, E1) exhibited the same pattern of staining and
colocalized with the mitochondrial marker CMX (Fig. 1 C2, D2, E2)
verifying the mitochondrial localization of the expressed protein in the
HepG2-mtGFPGR cells (Fig. 1 C4, D4, E4). Aswas expected, the presence
of dexamethasone induced nuclear translocation of the endogenous GR
(Fig. 1B1). Dexamethasonedidnot cause any changes in thedistribution
of the stably expressedmtGFPGR protein (Fig. 1 D1). HepG2 cells stably
expressing mtGFPGR showed a 2–3 fold increase in the mtGFPGR
expression compared to endogenousmtGR as indicated byWestern blot
analysis (Fig. 1F, lane 3). Western blot analysis of GR in subcellular
fractions of HepG2-mtGFPGR cells as well as immunoprecipitation
analysis ofGR inmitochondrial fractionsusing speciﬁc antibodies against
a) GR (Fig. 1F, lane 6) or b) GFP proteins (Fig. 1F, lane 7) veriﬁed the
mitochondrial localization of themtGFPGR protein (Fig. 1F lanes 3, 6, 7)
and its absence from the cytosolic fraction (Fig. 1F lane 2). Interestingly,
the co-immunoprecipitation of the endogenous, approximately 90 kDa,
mitochondrial GR protein with the mtGFPGR protein by the anti-GFP
antibodies, was also observed. HepG2 cells stably overexpressing
mitochondrial targeted GFP protein (HepG2-mtGFP cells) were also
produced, checked for the mitochondrial localization of the mtGFP
protein (data not shown), and used as control.
Fig. 1. Mitochondrial localization of glucocorticoid receptor in HepG2 cells. Mitochondrial localization of GR in HepG2 cells in the absence (A) or presence (B) of DEX. Methanol-
aceton ﬁxed specimens pretreated with CMX (A2, B2) were subjected to indirect immunoﬂuorescence staining of GR using the GR-H300 polyclonal antibodies (A1, B1). White
arrows indicate colocalization of GR with CMX. Expression and mitochondrial localization of mtGFPGR in methanol-aceton ﬁxed specimens of HepG2-mtGFPGR cells in the absence
(C, E) or presence (D) of DEX. C1, D1, and E1: mtGFPGR localization; C2, D2, and E2: CMX mitochondrial staining; A3, B3, C3, D3, and E3: nuclear staining of HepG2 cells with the
Hoechst 33342 dye; and A4, B4, C4, D4, and E4: merged images. Bars in A–B, C–D and E indicate 10, 50 and 25 μm, respectively. F: Western blot analysis of GR in subcellular fractions
of HepG2-mtGFPGR cells and immunoprecipitation analysis of mtGR and mtGFPGR in mitochondrial extracts from HepG2-mtGFPGR cells. Detection of GR in HepG2-mtGFPGR cells
was achieved byWestern blot analysis, applying the GR-H300 antibodies. The anti-GR (2F8) and anti-GFP antibodies were applied in immunoprecipitation studies; lane 1: total cell
extract; lane 2: post mitochondrial supernatant; lane 3: 10% of mitochondrial extracts used for immunoprecipitation; lanes 4 and lane 5: 10% of unbound mitochondrial proteins
immunoprecipitated with the anti-GR and anti-GFP antibodies, respectively; and lanes 6, 7, and 8: immunoprecipitated mitochondrial proteins with the anti-GR, anti-GFP
antibodies, and normal mouse IgG, respectively.
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transcription factors and of mitochondrial OXPHOS genes in HepG2 cells
HepG2 cells were induced with 1×10−6 M dexamethasone and the
transcription of the genes for the mitochondrial transcription factorsTFAM, TFB1M, TFB2M, the nuclear and mitochondrial OXPHOS genes,
and the mitochondrial 12 S and 16 S ribosomal RNA was assayed by
RT-PCR (see Materials and methods). The results are shown in Fig. 2. In
HepG2 cells the presence of dexamethasone led to increased transcrip-
tion of several genes, among them the mitochondrial transcription
Fig. 2. Effect of DEX onmitochondrial RNA transcription. A, B) HepG2 cells grown on 6 well plates were treated with 10 μg/mlα-amanitin, for 5 h at 37 °C.α-amanitin treated as well
as non treated cells were further incubated in the presence or absence of 10−6 M DEX diluted in ethanol, for 1 h at 37 °C. Control cells were incubated with equal volume of ethanol.
Subsequently cells were washedwith phosphate buffer saline and subjected to RNA extraction. ExpressedmRNA levels of A) nuclear encodedmitochondrial transcription factors and
B) COX IV, mitochondrial encoded OXPHOS and mitochondrial ribosomal RNAs were quantiﬁed by real-time PCR. HepG2-mtGFP (C) and HepG2-mtGFPGR cells (D) were also
subjected to α-amanitin treatment as described above, and subsequently stimulated with DEX or equal volumes of ethanol, for 1 h at 37 °C. mRNA levels measurements were
performed applying real-time PCR. Expressed levels of GAPDH were measured for the normalization of the results. Results are expressed as fold induction of the indicated DEX
induced gene expression, in the absence (DEX) or presence of α-amanitin (AM), compared to the GAPDH gene expression, and represent the mean±SD of at least three individual
experiments. ⁎Pb0.05; ⁎⁎Pb0.005; A. Compared to DEX induction in the absence of α-amanitin; B. Compared to α-amanitin effect on nuclear encoded COX IV gene; D. Compared to
DEX induction in HepG2-mtGFP cells.
1818 A.-M.G. Psarra, C.E. Sekeris / Biochimica et Biophysica Acta 1813 (2011) 1814–1821factors examined (Fig. 2A), the mitochondrial 12 S and 16 S RNA and
several mitochondrial OXPHOS genes such as NADH-CoQ-reductase
subunits I–IV (ND I–IV), cytochrome b (Cyt b), ATP-synthase 6 and
8 (ATP 6 and ATP 8), and COX I (Fig. 2B).
In order to evaluate the contribution of the dexamethasone induced
increase in transcription of the mitochondrial transcription factors and
the mitochondrial encoded genes, we repeated the experiments
depicted in Fig. 2 in the presence of concentrations of α-amanitin
known to inhibit HnRNA synthesis and also inhibit dexamethasone
induction of gluconeogenic liver enzymes [20,21]. α-amanitin is an
inhibitor of DNA dependent RNA polymerase II. Administration of
amanitin to animals or cells leads to inhibition also of other RNA types,
such as ribosomal RNA, however mitochondrial RNA synthesis is not
affected [20,22,23]. As demonstrated in Fig. 2A, α-amanitin almost
completely blocked the dexamethasone effect on TFAM, TFB1M and
TFB2M transcription, (exhibiting induction of transcription of those
genes similar to the GAPDH gene used for the normalization of the
results). In contrast, in the presence of α-amanitin the dexamethasone
induced expression of the mitochondrial encoded genes could still
proceed (Fig. 2B). In addition, the effects of dexamethasone on OXPHOS
gene expression, in HepG2-mtGFPGR cells, were more pronounced,
particularly genes encoding ND II, Cyt b, 16 S, ATP 6, ATP 8, COX I, ND IV
ND V showed a 3–4 fold induction and which was 1.5–2 fold of the
induction observed in HepG2-mtGFP cells (Fig. 2C, D). α-amanitin
occasionally reduced transcription of the mitochondrial genes, but still
permitted dexamethasone induction of these genes to an extent of
70–100% in respect to cells not treated with the α-amanitin.
3.3. Effect of mitochondrial GR on mitochondrial transcription in an
organello system
The DEX induced mitochondrial RNA expression which was more
pronounced in HepG2-mtGFPGR cells prompted us to examine themitochondrial RNA synthesis in a faithfully transcribing mitochondrial
organello system. Isolated mitochondria from HepG2-mtGFPGR cells
showed increased capacity to synthesize RNA compared to equal
amounts ofmitochondria fromcontrolHepG2-mtGFP cells (Fig. 3A). The
presence of dexamethasone causes an approximately 1.5–2 fold
induction in mitochondrial transcription of isolated mitochondria of
HepG2-mtGFPGR cells (Fig. 3B) whereas, in the presence of the GR
antagonist, RU486, the effect of DEX on themitochondrial transcription
is diminished.
3.4. Binding of GR to the mitochondrial DNA
The effects of dexamethasone on mitochondrial gene transcription
in an organello system and in HepG2 cells, even in the presence of
a-amanitin, supported the direct effect of GR on mitochondrial
transcription, presumably as a consequence of binding of the receptor
to the mitochondrial genome. To test this assumption a ChIP analysis
of GR binding to mitochondrial DNA, particularly to the mitochondrial
gene sequences showing homology to glucocorticoid responsive
elements, was performed (Fig. 4).
The result of the ChIP analysis revealed binding of themitochondrial
GRmainly to the regulatoryD-loop region of themitochondrial genome.
Other less prominent binding sites were found in the 12 S and NADH I
region of the mitochondrial genome. The immunoprecipitated DNA by
ChIP analysis was detected and quantiﬁed either by semi-quantitative
PCR (Fig. 4A) or real-time PCR (Fig. 4B, C).
3.5. Induction of COX I protein synthesis by the mitochondrial GR
The glucocorticoid induced activation of the mitochondrial
transcription by the mitochondrial glucocorticoid receptor prompted
as to examine whether the increased mitochondrial receptor
localization also affects OXPHOS enzyme biosynthesis. For that
Fig. 3. Mitochondrial RNA synthesis in an organello system. A. Mitochondrial RNA synthesis was measured in equal amounts of isolated mitochondria from HepG2-mtGFP and
HepG2-mtGFPGR cells as described in material and methods. Mitochondrial RNA synthesis was evaluated by measuring [α-32P]UTP incorporation into synthesized RNA B.
Mitochondrial RNA synthesis wasmeasured in equal amounts of isolatedmitochondria fromHepG2-mtGFPGR cells in the presence or absence of 10−6 MDEX and/or 10−5 M RU486.
Results are expressed as fold induction of mitochondrial transcription relative compared to A) HepG2-mtGFP cells, B) untreated HepG2-mtGFPGR cells and represent the mean±SD
of at least three individual experiments. ⁎Pb0.05.
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-mtGFPGR cells, following stimulation of the cells either with DEX or
ethanol at a ﬁnal concentration of 10−6 M and 0.1%, respectively, for
6 h. β-actin was used for the normalization of the results. As shown in
Fig. 5, overexpression of mitochondrial GR caused increase in COX I
protein synthesis in both cases examined.
3.6. Effect of mitochondrial GR on mitochondrial ATP content
Mitochondrial GR translocation should be closely associated with
the energy status of the cell and may constitute a regulatory
mechanism of the cell to face its energy demands. In our model
system, the activation of the mitochondrial transcription and OXPHOS
enzyme biosynthesis by the stable overexpression of mtGR may also
lead to increase in mitochondrial capacity to produce ATP. To test this
hypothesis, mitochondrial ATP level of HepG2-mtGFP and HepG2-
mtGFPGR cells, preincubated or not with 10−7 M DEX for 16–20 h,
was measured as described in material and methods. HepG2-
mtGFPGR cells showed an approximately 1.5–2 fold increase in ATPFig. 4. Binding of the glucocorticoid receptor to the D-loop of the mitochondrial DNA of HepG
(2F8) or nonspeciﬁc IgG as described in Materials and methods. Levels of immunopreci
mitochondrial D-loop, the NADH dehydrogenase I gene and the 12 S gene were assessed eit
gene was used as negative control. The results of three independent experiments as means±
DNA sequences. Recovery of DNAwas calculated as percentage of input material of the immu
indicated by arrows.level compared to control cells. DEX causes an approximately 20%
increase inmitochondrial ATP content in HepG2-mtGFP cells, whereas
ATP level in HepG2-mtGFPGR cells is not signiﬁcantly affected by DEX.
Preincubation of cells with 0.2 μM rotenone for 16–20 h in the
presence or absence of DEX caused elimination in mitochondrial ATP
production in both cell lines examined (Fig. 6).
4. Discussion
The mode of action of glucocorticoids on target cells has been a
ﬁeld of intense experimentation, following the seminal observation
that steroid hormones act by way of gene activation [review in
10,12,24]. The induction of gluconeogenic enzymes in the rodent liver
was one of the early models to test the hormone–gene activation
hypothesis and was instrumental, among other models, to validate
the hypothesis [2–6]. An early intriguing ﬁnding was the massive
induction of RNA synthesis by glucocorticoids in the liver cells,
encompassing all types of RNA-HnRNA, ribosomal RNA, t-RNA, most
of which was degraded in the nucleus. Importantly, it has been2 cells. HepG2 cells were subjected to a ChIP assay using speciﬁc antibodies against GR
pitated DNA encompassing the putative hormone response elements located in the
her by semiquantative PCR (A) or real-time PCR (B, C). 10% input was used. Myoglobin
S.D. are shown in B, C and represent the recovery and occupancy of the mitochondrial
noprecipitation. D. The mammalian mitochondrial genome. Sites of primers location are
Fig. 5. Activation of COX I protein synthesis in HepG2 cells by the mitochondrial GR.
Equal amounts of total protein extracts from HepG2-mtGFP (1) and HepG2-mtGFPGR
(2) cells were examined for COX I protein expression applying Western blot analysis.
Protein levels of β-αctin were used for the normalization of the results.
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[3,6]. Recent results from bioarray analyses reveal many different
functional gene classes regulated by glucocorticoids. These functional
classes include genes involved in energy metabolism, signal trans-
duction, cell proliferation and differentiation, immune response,
transcription, apoptosis, redox regulation, protein transport system,
and protein trafﬁcking [7–9]. Although the results from bioarrays can
account for part of the induced RNA, the nature of the rapidly turning-
over nuclear RNA is still unknown, and could involve the recently
discovered various types of regulatory RNA molecules, discussed by
various authors [25,26]. The hormonal mobilization of the transcrip-
tional, post transcriptional and translational machinery of the cell is
highly energy consuming and indeed, among the proteins induced by
glucocorticoids, are enzymes involved in energy production, e.g.
OXPHOS, some encoded by the nuclear and some by the mitochondrial
genome. How glucocorticoids induce and coordinate transcription of
genes in twodifferent cell organelles is generally accepted as the effect of
the hormone on nuclear OXPHOS genes and on nuclearly encoded
mitochondrial transcription factors, which subsequently enter the
mitochondrion to inducemitochondrialDNA transcription. Thepresence
of glucocorticoid receptors inmitochondria andof GRE-like sequences in
themitochondrial genome suggested an additionalmode, a direct-effect
of the mitochondrially localized receptor in mitochondrial transcription
[11,13]. To test this hypothesis HepG2 hepatocarcinoma cells, which
stably express a mitochondrial targeted GFPGR or a mitochondrial
targetedGFP proteinwere produced andexamined for their efﬁciency to
activate mitochondrial transcription in the presence of DEX and/orFig. 6. Effect of mitochondrial GR on mitochondrial ATP level in HepG2 cells. Equal
number of HepG2-mtGFP and HepG2-mtGFPGR cells were grown on 15 cm dishes. At
70–80% conﬂuency cells were incubated or not with 0.2 μΜ rotenone (diluted in DMSO)
in the absence or presence of 10−7 M DEX (diluted in EtOH), for 16 h, at 37 °C. Control
cells were incubated with equal volumes of DMSO and/or EtOH, respectively.
Subsequently cells were washed with PBS, harvested, homogenized, and subjected to
crude mitochondrial isolation as described previously [17]. Mitochondrial ATP content
of isolated mitochondria was measured by bioluminescence assay as described in
material and methods. Results are expressed as arbitrary units of luciferase activity/mg
of mitochondrial protein and represent the mean±SD of at least three independent
experiments. ⁎Pb0.05 compared to HepG2-mtGFP untreated cells; ⁎⁎Pb0.001,
compared to similarly treated HepG2-mtGFP cells.α-amanitin, the well known inhibitor of the DNA dependent RNA
polymerase II [20,22,23], which in vivo inhibits not only HnRNA, but
also ribosomal and t-RNA synthesis, but does not affect mitochondrial
transcription [20,22]. Both non-transfected and stably transfected cells
reacted to the addition of dexamethasone with an increased
mitochondrial transcription. Among the genes induced were the
genes encoding the mitochondrial ribosomal 12 S and 16 S RNA, and
themitochondrial encoded OXPHOS genes ND I, ND II, ND III, ND IV, Cyt
b, ATP 6, ATP 8, and COX I. In HepG2 cells DEX also caused induction of
the mitochondrial transcription factors TFAM, TFB1M, and TFB2M.
As was expected, in the presence of α-amanitin; the dexameth-
asone induced expression of the nuclearly encoded mitochondrial
transcription factors genes TFAM, TFB1M, and TFB2M was inhibited.
The important ﬁnding was that in spite of the inhibition of the
nuclearly encoded transcription factors, mitochondrial gene tran-
scription although occasionally attenuated, still was induced to a level
of 70–100% in respect to cells not treated with the α-amanitin. This
leads us to conclude that certainly there is a nuclear contribution to
the dexamethasone mitochondrial transcription induction, but that
dexamethasone can also affect directly the mitochondrial transcrip-
tion apparatus by way of the mitochondrial GR. This is also supported
by the ﬁnding of a direct GR-mitochondrial DNA interaction,
speciﬁcally on the regulatory D-loop site, which was identiﬁed in
previous publications as a potential GR binding site on the basis of its
sequence homology to GREs, by gel retardation assays and by
transfection experiments [27–29].
The hypothesis of a direct effect of GR on mitochondrial transcrip-
tion with a mode of action similar to that of the nuclear receptor is
further supported by our observations showing increased RNA
synthesis in a mitochondrial organello system of HepG2-mtGFPGR
cells in the presence of DEX and attenuation of this induction in the
presence of the GR antagonist, RU486. Moreover, the observed
co-immunoprecipitation of the endogenous mtGR with the mtGFPGR
by the GFP antibodies may indicates the existence of GR-mtGFPGR
interactions in the mitochondrial environment of HepG2-mtGFPGR
cells. Experiments are underway to identify mitochondrial GR partners,
and other regulatory molecules that participate in the GR-induced
activation of the mitochondrial transcription. GR molecules and their
interacting partners may constitute regulatory components of the
mitochondrial nucleoid structure that contains mtDNA and DNA
binding proteins and is well established that exert crucial role in
mtDNA replication and transcription [30,31]. Recently it is proposed
that nucleoids may play an even broader role in mitochondrial
biogenesis [31], a process that is also suggested to be regulated by
streroid and thyroid hormones [10,32–34].
The activation of the mitochondrial mRNA synthesis by increased
expression of the mitochondrially localized glucocorticoid receptor
may also lead to activation of OXPHOS enzyme biosynthesis, as
indicated by our results showing increased COX I protein synthesis in
HepG2-mtGFPGR cells, and subsequently to increase in mitochondrial
ATP content, as was observed in our experimental model. DEX did not
signiﬁcantly affect the capacity of mitochondria to produce ATP in
HepG2-mtGFPGR cells. This effect may suggest the existence of
regulatory and feedback mechanisms that control and suppress the
excess OXPHOS enzyme biosynthesis and activation. In this context,
changes in intramitochondrial ATP levels have been proposed as a
regulatory mechanism for mitochondrial mRNA synthesis and
OXPHOS enzyme activation [14,35]. The elimination in ATP content
in the presence of rotenone, an inhibitor of respiratory chain, veriﬁed
the mitochondrial origin of the GR-induced increase in ATP
production.
In addition to GR, other steroid and thyroid receptors have been
detected in mitochondria and important efforts have been devoted
towards elucidating the role of these receptors in mitochondria
[10,36,37]. A speciﬁc type of mitochondrial thyroid receptor was
found by Casas et al. [16] and a direct effect of T3 on mitochondrial
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has been shown establishing the role of the mitochondrial thyroid
receptor [14,15,32,33,38]. Estrogen and androgen, receptors have also
been found in mitochondria of several types of cells and their
involvement in the regulation of mitochondrial functions has been
proposed [reviewed in 13,36–40]. Recently the involvement of the
mitochondrial glucocorticoid receptor in the regulation of the
glucocorticoid-induced apoptosis andmodulation of cellular plasticity
has been suggested [41,42].
The present work gives the ﬁrst insights into the molecular
mechanisms underlying the GR-mediated mitochondrial transcription
providing evidence for a direct involvement of the mitochondrially
localized glucocorticoid receptor in the regulation of mitochondrial
transcription and OXPHOS enzyme biosynthesis by binding to mtDNA
and activation ofmitochondrial gene expression.Moreover, results from
this study prove that this action takes place in addition to a nuclear
action of glucocorticoids onmitochondrial genes byway of induction of
genes of the nuclearly encoded mitochondrial transcription factors,
which then enter mitochondria to regulate mtDNA transcription and
OXPHOS enzyme biosynthesis.
Recently, in addition to nuclear receptors, the mitochondrial
localization of several other transcription factors with nuclear actions
including NF-κΒ, p53, AP-1, STAT-3 but with increasing importance
for mitochondrial functions has been suggested [36,43–45]. The
mitochondrial localization of these molecules potentiates their
regulatory signiﬁcance and renders them coordinators of nuclear
and mitochondrial actions in important functions, among them
energy production, mitochondrial dependent apoptosis, oncogenic
transformation and immune responses [36,39–45].
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